A new study finds 60% of heart disease patients have uncontrolled cholesterol, many aren’t on recommended cholesterol-lowering medications.

A team led by Rohit Singh, PhD, has developed a computational technique that allows large language models to predict antibody structures more accurately.

Samuel Katz, MD, who chaired the Department of Pediatrics for 22 years, was a role model for integrating science and clinical care.

After a thorough national search, Aditee Narayan, MD, MPH, has been appointed Vice Dean for Education at Duke University School of Medicine, effective January 1, 2025. 

Devdutta Sangvai, MD, is a professor in the Department of Family Medicine and Community Health at Duke and will be the first Indian-American Cabinet member.

Join Dr. Klotman and her family as they share holiday cheer and reflect on the remarkable milestones achieved by our school this year. From groundbreaking research to impactful community partnerships, this festive message encourages everyone to prioritize health and well-being during the holiday season. Let's look forward to an even more successful 2025 together.

Zhao Zhang, PhD , associate professor of pharmacology and cancer biology, has been named a recipient of the 2024 Distinguished Scientist Award from The Sontag Foundation.

Over the years as an occupational therapist, Omar Mohiuddin, OTR/L, MS, MPH, CLVT, came to realize that many accessibility issues often go unaddressed, even in spaces originally designed with older adults and persons with visual impairment in mind. That realization fueled his passion for accessibility and drives his devotion to improving the day-to-day lives of persons with blindness and low vision.

Duke University School of Medicine’s BOOST Program recently celebrated 20 years of inspiring young people to pursue careers in science, technology, engineering, and medicine (STEM).

In 2017, JaNiece and Randy Saladin were devastated to learn that their 8-month-old-son, Randall, had a brain tumor. Today, Randall is thriving thanks to support from the Duke Pediatric Neuro-oncology Program team and a breakthrough FDA-approved drug.